Christoph Nossing
Garscube Estate
Glasgow, SCT, United Kingdom
Glasgow, SCT, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Rethinking EZH2 Inhibition: A Priming Strategy for EGFR-targeted Therapy in Bladder Cancer.
Journal: European urology oncology
Published: July 28, 2026
ABCG2-mediated SN-38 efflux drives resistance to Sacituzumab govitecan in urothelial carcinoma.
Journal: Cancer letters
Published: August 11, 2025
Advances in preclinical assessment of therapeutic targets for bladder cancer precision medicine.
Journal: Current opinion in urology
Published: April 11, 2024
Species-specific cleavage of the autophagy adaptor p62 dictates responses to TNF.
Journal: Molecular cell
Published: January 31, 2024
Clofarabine Has a Superior Therapeutic Window as compared to Gemcitabine in Preclinical Bladder Cancer Models.
Journal: European urology oncology
Published: January 12, 2024
50 years on and still very much alive: 'Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics'.
Journal: British journal of cancer
Published: October 03, 2022
ATG7 is a haploinsufficient repressor of tumor progression and promoter of metastasis.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: July 22, 2022
Complementary omics strategies to dissect p53 signaling networks under nutrient stress.
Journal: Cellular and molecular life sciences : CMLS
Published: January 03, 2022
Showing 1-11 of 11
Last Updated: 09/26/2026